Search research articles
Contact Us
Filters
Showing results (121-130 of 2,246) with videos related to
Page
of 225
Sort By:
ESMO Open
|
February 21, 2021
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial
A Camerini, A Morabito, A Montanino, et al.
ESMO Open
|
September 27, 2019
Liquid biopsy assessment of synchronous malignancies: a case report and review of the literature
Sandra Liebs, Anika Nonnenmacher, Frederick Klauschen, et al.
ESMO Open
|
September 27, 2019
B7x-from bench to bedside
Gurbakhash Kaur, Murali Janakiram
ESMO Open
|
September 27, 2019
UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)
Ines Vaz-Luis, Paul Cottu, Christel Mesleard, et al.
ESMO Open
|
August 20, 2019
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
Juan-Miguel Cejalvo, Wolfgang Jacob, Tania Fleitas Kanonnikoff, et al.
ESMO Open
|
August 20, 2019
Targeting prognostic proinflammatory biomarkers to improve outcome on IO drugs
John Haanen
ESMO Open
|
August 20, 2019
How I treat metastatic melanoma
Reinhard Dummer, Joanna Mangana, Anna Lisa Frauchiger, et al.
ESMO Open
|
August 20, 2019
How I treat ALK-positive non-small cell lung cancer
Michael G McCusker, Alessandro Russo, Katherine A Scilla, et al.
ESMO Open
|
August 20, 2019
How I treat cancer: treatment of rheumatological side effects of immunotherapy
Karolina Benesova, Hanns-Martin Lorenz, Jan Leipe, et al.
ESMO Open
|
August 20, 2019
How we treat neurological toxicity from immune checkpoint inhibitors
Lavinia Spain, Zayd Tippu, James M Larkin, et al.
Page
of 225
Search research articles
Search
Showing results (121-130 of 2,246) with videos related to
Sort By:
Page
of 225
ESMO Open
|
February 21, 2021
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial
A Camerini, A Morabito, A Montanino, et al.
ESMO Open
|
September 27, 2019
Liquid biopsy assessment of synchronous malignancies: a case report and review of the literature
Sandra Liebs, Anika Nonnenmacher, Frederick Klauschen, et al.
ESMO Open
|
September 27, 2019
B7x-from bench to bedside
Gurbakhash Kaur, Murali Janakiram
ESMO Open
|
September 27, 2019
UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)
Ines Vaz-Luis, Paul Cottu, Christel Mesleard, et al.
ESMO Open
|
August 20, 2019
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
Juan-Miguel Cejalvo, Wolfgang Jacob, Tania Fleitas Kanonnikoff, et al.
ESMO Open
|
August 20, 2019
Targeting prognostic proinflammatory biomarkers to improve outcome on IO drugs
John Haanen
ESMO Open
|
August 20, 2019
How I treat metastatic melanoma
Reinhard Dummer, Joanna Mangana, Anna Lisa Frauchiger, et al.
ESMO Open
|
August 20, 2019
How I treat ALK-positive non-small cell lung cancer
Michael G McCusker, Alessandro Russo, Katherine A Scilla, et al.
ESMO Open
|
August 20, 2019
How I treat cancer: treatment of rheumatological side effects of immunotherapy
Karolina Benesova, Hanns-Martin Lorenz, Jan Leipe, et al.
ESMO Open
|
August 20, 2019
How we treat neurological toxicity from immune checkpoint inhibitors
Lavinia Spain, Zayd Tippu, James M Larkin, et al.
Page
of 225